Post-operative adjuvant thoracic radiotherapy for patients with completely resected non-small cell lung cancer with nodal involvement: outcome and prognostic factors
- 1 January 2004
- journal article
- Published by Oxford University Press (OUP) in The British Journal of Radiology
- Vol. 77 (913) , 43-48
- https://doi.org/10.1259/bjr/21845347
Abstract
The purpose of this study was to analyse the outcome and prognostic factors of non-small cell lung cancer (NSCLC) patients with nodal disease treated by complete tumour resection followed by radiotherapy alone. Between October 1990 and October 1999, 49 NSCLC patients with N1 or N2 stage were treated with complete resection of tumour followed by post-operative radiotherapy in our department. The radiation was delivered with 10 MV X-rays given 5 days per week at 1.8-2 Gy per fraction. Total doses ranged from 40 Gy to 64.8 Gy, with a median dose of 55.8 Gy. All patients had at least 30 months of follow-up. The 5 year overall survival rate (OS), local control rate (LC) and distant metastasis-free rate (DMF) were 34%, 52% and 29%, respectively. In multivariate analysis, stage and margin were found to influence OS. The total number of involved lymph nodes and positive margins were significant factors for LC. Only N stage was found to correlate with DMF. In conclusion, patients with multiple involved lymph nodes, advanced stage or positive surgical margins had a poor outcome even with post-operative radiotherapy. Based on these prognostic factors, new therapeutic regimens and modalities for NSCLC need to be further investigated.Keywords
This publication has 26 references indexed in Scilit:
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Postoperative Radiation Therapy in Non-Small Cell Lung CancerAmerican Journal of Clinical Oncology, 1997
- Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patientsCancer, 1995
- A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study)European Journal of Surgical Oncology, 1995
- A Phase 3 Randomized Trial of Immediate Combination Chemotherapy vs Delayed Combination Chemotherapy in Patients With Completely Resected Stage II and III Non-small Cell Carcinoma of the LungChest, 1994
- Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Postoperative adjuvant treatments for non-small cell lung cancers: a consensus reportLung Cancer, 1991
- Postoperative radiation therapy in lung cancer: A controlled trial after resection of curative designInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Basis for new strategies in postoperative radiotherapy of bronchogenic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958